HC Wainwright & Co. : Reiterate the OptiNose (OPTN.US) rating and adjust it from buy to buy, with a target price of $5.00.

HC Wainwright & Co. : Reiterate the OptiNose (OPTN.US) rating and adjust it from buy to buy, with a target price of $5.00.

Zhitong FinanceApr 29 18:20

Analysts' Top Healthcare Picks: Longeveron (LGVN), Optinose (OPTN)

TipRanksApr 29 18:20

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first

BenzingaApr 26 01:57

Market-Moving News for April 25th

ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.CDTX: 41% | Cidara Therapeutics shares are trading higher after the company announc

BenzingaApr 25 20:31

Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist

BioPharmCatalystApr 25 20:26

Optinose Provides Corporate Updates; Expects To Produce Positive Income From Operations For Full Year 2025

In addition, the Company announced preliminary XHANCE net product revenue of $14.9 million for the three months ended March 31, 2024, representing growth of approximately 26% over the first quarter of

BenzingaApr 25 19:29